Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
Notified -
Globe Newswire23-10-2025, 23:30
African governments harness education data to reverse learning crisis 9-05-2023, 15:16